Rational Combinations 360º by The Conference Forum

3rd annual Rational Combinations 360º is organized by The Conference Forum (TCF) and will be held from Sep 13 - 14, 2018 at Wyndham Philadelphia Historic District, Philadelphia, Pennsylvania, United States of America.

The target audience for this medical event is designed for all size pharma/biotech companies and investors seeking to accelerate clinical trials in the emerging immuno-oncology space.

Course Description:
Rational Combinations 360° provided the most up-to-date research, data and progress on combination developments to help IO stakeholders:
• Be at the forefront of the most relevant research and developments for IO combinations from key leaders who are at the pulse of cancer immunotherapy
• Foster collaboration amongst others working in all aspects of cancer immunotherapy by rounding up all stakeholders under one roof
• Receive the latest pre-clinical, translational and clinical data from academia and industry
• Better understand what assets are available for potential combinations that may be able to give patients more treatment options
• Create and prioritize combination strategies targeted toward specific tumor types
• Get key investor and analyst evaluations and insights on the IO combination landscape
• Learn about biomarker advancements, neoantigen approaches and more
• Obtain coverage on a wide range of emerging technologies

The Rational Combinations 360° is a comprehensive program providing exposure to the entire spectrum of RandD, addressing key aspects across all facets of combination immunotherapies including:
• Discovery / Preclinical Science
• Translational Science
• Clinical Operations and Development
• Business Aspects
• Financial and Commercial Implications
• Emerging Technologies
• Biomarkers and Diagnostics
• Trends in the Field

Time:08:00 am to 06:00 pm

Prices:
Pharma and Biotech standard rate: USD 1895.0,
Standard Industry standard rate: USD 1895.0,
Academia, Non-Profit and Government standard rate: USD 947.5

Speakers: Ohad Amit, PhD, Roy Baynes, MD, PhD, Jeffrey Bockman, PhD, Marcus Bosenberg, MD, PhD, Amanda Bruno, PhD, Lauren Byers, MD, Daniel Chen, MD, PhD, Jonathan Fassberg, David Giljohann, PhD, Lindee Goh, PhD, Asthika Goonewardene, Philip Gotwals, PhD, Carol Haddad, , Axel Hoos, MD, PhD, Patrick Hwu, MD, Dirk Jäeger, MD, Maria Jure-Kunkel, PhD, Michael Kalos, PhD, Michael King Jr, Theresa LaVallee, PhD, Ke Liu, MD, PhD, Roger Longman, Jason Luke, MD, Ian McCaffery, PhD, Erin Newburn, PhD, Mark Paris, PhD, Steven Rosenberg, MD, PhD, Ruth Rutledge, Mark A Socinski, MD, Jennifer Wargo, MD, Lei Zheng, MD, PhD

Additional details will be posted as soon as they are available.